SAN FRANCISCO, June 23, 2025 (GLOBE NEWSWIRE) -- AltruBio Inc. (“AltruBio” or “the Company”), a clinical stage biotech company developing novel immune checkpoint enhancers to address the unmet need in ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exo Therapeutics, Inc., a company developing a pipeline of drug candidates that target exosites, unique small-molecule binding pockets that are distal to traditional ...
GAITHERSBURG, Md., May 22, 2023 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI), a biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune ...
Pazar formában van Szoboszlai Dominik: a magyar válogatott csapatkapitánya az elmúlt kettő Premier League-mérkőzésen kettő ...